Overview

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The current study is designed to test the efficacy, safety and tolerability of LCP-AtorFen, a combination of atorvastatin and fenofibrate.
Phase:
Phase 2
Details
Lead Sponsor:
Veloxis Pharmaceuticals
Treatments:
Atorvastatin
Atorvastatin Calcium
Fenofibrate